Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.
about
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attackIntensive versus conventional glycaemic control for treating diabetic foot ulcersInsulin for glycaemic control in acute ischaemic strokePeroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attackCarotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetesVitamin D, carotid intima-media thickness and bone structure in patients with type 2 diabetes.Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial.Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial.Treat-to-target trials in diabetes.Prediction of excessive weight gain in insulin treated patients with type 2 diabetes.Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy.Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
P2860
Q24186319-4002BD3D-E33B-426D-9184-029AE7E8AD87Q24186487-9143B59C-84BF-42E1-B974-7AB602F586A1Q24201046-9D596CD1-781E-491B-9078-D8651ED9D393Q24201174-30B0CEC7-8342-4BBF-9C57-605B827C5EE4Q34721194-A2033E6C-6DED-48A8-98DE-1E11393A6482Q35721977-43F930DF-AC29-4B82-8FB6-6DB9BD7BDE7FQ36633074-596D6786-FCCB-4BF2-AAB3-318625D7BB6FQ36633079-1CD120A0-B680-4DD5-9D08-8B526CBEE18BQ37703688-501A1EA6-DBD9-408A-A751-F0F04C9ED73DQ39808718-44F73535-6810-4D33-8D02-B46CCAE5A846Q42577172-6B9EFA78-D2F6-405E-BD17-1D8D62DC2E36Q47380989-99D85E0F-D66D-42B6-A1DE-69696B2316C8
P2860
Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Study rationale and design of ...... n and Metformin Therapy trial.
@en
Study rationale and design of ...... n and Metformin Therapy trial.
@nl
type
label
Study rationale and design of ...... n and Metformin Therapy trial.
@en
Study rationale and design of ...... n and Metformin Therapy trial.
@nl
prefLabel
Study rationale and design of ...... n and Metformin Therapy trial.
@en
Study rationale and design of ...... n and Metformin Therapy trial.
@nl
P2093
P50
P1476
Study rationale and design of ...... n and Metformin Therapy trial.
@en
P2093
B Gade-Rasmussen
B Thorsteinsson
C Hedetoft
CIMT Trial Group
E Mathiesen
P304
P356
10.1111/J.1463-1326.2008.00959.X
P577
2009-04-01T00:00:00Z